March 05, 2026

Did Medicine Lose Its Aura Before AI?

From the clinical gaze to electronic health records, a JAMA essay traces the long technological arc that set the stage for AI in medicine.

Conexiant

March 05, 2026

AI Model Finds Hidden Risk Signals in CGM Data

GluFormer accurately identified patients likely to experience clinically meaningful rises in HbA1c over a 2-year period.

Conexiant

March 05, 2026

Hidden Risk: Clinician Substance Use

Longitudinal Swedish study finds physicians and nurses reporting problem drinking or illicit drug use had about twice the risk of rating their care as poor 1 year later

Conexiant

March 05, 2026

Medical Oddities: The Calmest Move in Cardiology?

Yoga for SVT, romantic brain bias, dog-made air chemistry, math learning clues, selenium tea, and glaucoma pillows—medicine’s weekly roundup of strange.

Conexiant

March 05, 2026

Comparing Brain Stimulation Strategies for Depression

Two transcranial magnetic stimulation protocols produced different short-term outcomes in patients with major depressive disorder

Conexiant

March 05, 2026

Do Suicide Efforts for Autism Start Too Late?

A UK survey identifies priorities for suicide prevention, highlighting the need for earlier support, improved diagnostic access, and community-informed services.

Conexiant

March 04, 2026

AI's Expanding Role in Diabetes Care

Machine learning models applied to inpatient electronic health record data have predicted insulin needs more accurately than traditional guidelines.

Conexiant

March 04, 2026

Diet-Microbiome Links Drive IBD Inflammation

Shotgun metagenomics links specific taxa and short-chain fatty acid pathways to reduced inflammation in Crohn’s disease and ulcerative colitis.

Conexiant

March 04, 2026

GROWell App Fails to Curb Pregnancy Weight Gain

Mobile health intervention does not significantly reduce excessive gestational weight gain or postpartum weight retention in randomized trial

Conexiant

March 04, 2026

Could This Tool Reduce Antidepressant Dropout?

The PETRUSHKA platform uses clinical data and patient-reported side-effect priorities to rank antidepressant options and guide shared treatment decisions.

Conexiant